MATERIALS AND METHODS: The study comprised 47 Year 4 pharmacy students in the pre- and post-practical phases (September 2018 and November 2018), followed by the post-resting phase (May 2019). The data collection form in the Sport Pharmacy course was used for the data collection.

RESULTS: Nearly half of the students initially displayed a normal body mass index (BMI). However, after the post-resting period, there was a noticeable increase in the number of students categorized as obese and those with elevated total cholesterol (TC) and fasting blood glucose (FBG) levels. Specifically, in the pre-study phase, out of 47 participants, 22 were within the normal BMI (47%), six underweight (13%), nine overweight (19%), and ten obese (21%). The intervention phase showed a slight reduction in the overweight category, while the obese category showed an increase. For TC, the pre-phase had 70% of participants within the normal range, with 26% borderline high and 4% high. Post-study, showed an improvement, likely influenced by controlled dietary intake and physical activity. In the post-resting phase, however, there was a regression as the majority did not adhere to the non-pharmacological regimen. FBG demonstrated significant changes after the intervention, particularly within the normal range (≤ 6.0 mmol/L), showing the only statistically significant change across parameters. While the post-resting phase saw a minor increase, it remained below baseline. Approximately 23% continued diet control, while 32% maintained physical activity. Key motivations included health improvement, visible results, and improved well-being, while lack of motivation, time, and study schedules were primary discontinuation factors.